Floraworks is a specialized supplier of hemp-derived cannabinoids for use in a wide variety of consumer and enterprise applications.

Recent News

  • CBN Has Become the Leading Growth Catalyst in the Cannabis Edible Market

    Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - FloraWorks Holdings Inc. ("FloraWorks" or the "Company") FloraWorks, is closely tracking the growth of CBN adoption within the hemp and cannabis industry. Using data from Headset, a leading cannabis market intelligence service, the company has created the Q1 2021 CBN Market Report to give you a glimpse into the early growth phase of the rapidly emerging market demand for CBN products.Cannabinol or CBN for short, is a rare cannabinoid once only...

    2021-05-04 10:00 AM EDT
  • Also Known as "The Sleep Cannabinoid", Cannabinol (CBN) Is Now Available in Commercial Quantities

    Vancouver, British Columbia--(Newsfile Corp. - June 9, 2020) - FloraWorks Holdings Inc. ("FloraWorks" or the "Company") Cannabinol (CBN), the rare cannabinoid often only found in trace amounts of aged cannabis has been shown to have unique physiological effects that have already started gaining traction for consumer health applications. FloraWorks is excited to announce that after significant research and development efforts, the Company is now manufacturing highly-pure, hemp-derived CBN isolate at scale, that is now commercially available for sale.FloraWorks strives to...

    2020-06-09 5:00 AM EDT